Neuronetics to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call
July 20, 2021 08:30 ET
|
Neuronetics
MALVERN, Pa., July 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers
July 14, 2021 08:15 ET
|
Neuronetics
MALVERN, Pa., July 14, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Set to Join Russell 2000® Index
June 23, 2021 17:29 ET
|
Neuronetics
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting
June 09, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., June 09, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Present at The JMP Securities Life Sciences Conference
June 03, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Names Todd Cushman as Vice President, Business Development
June 01, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., June 01, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Present at the William Blair 41st Annual Growth Stock Conference
May 20, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., May 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center
May 17, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports First Quarter 2021 Financial and Operating Results
May 04, 2021 07:00 ET
|
Neuronetics
MALVERN, Pa., May 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences
May 03, 2021 08:00 ET
|
Neuronetics
MALVERN, Pa., May 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...